CAD for Mammography

Breast cancer is the leading cause of cancer death in women ages 40-59. In 2005 an estimated 211,240 new cases of invasive breast cancer are expected to occur among women in the United States. An estimated 40,410 women will die from this disease. Statistics show that 1 out of 8 women will be diagnosed with breast cancer. The chances of cure improve dramatically if cancers are caught at an early stage. [read more]

R2 Technology CAD for mammography received FDA approval in 1998 and provides integrated solutions for both film-screen and digital mammography.

• R2 marks 50% more of the difficult cases as compared to the competition.
• R2 has the lowest false-positive rate with only 1.4 false-positive marks on a normal case.
• R2 has twice the sensitivity on architectural distortions as the competition.
• R2's mass algorithm detects densities, asymmetries, and architectural distortions that can be characteristic of a breast cancer.
• R2's sensitivity detects 98% of calcifications and 90% of masses.

More Breast Cancer Information     Compare R2's Algorithm